Page last updated: 2024-09-05

deferasirox and Congenital Erythropoietic Porphyria

deferasirox has been researched along with Congenital Erythropoietic Porphyria in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abkowitz, JL; Egan, DN; Phillips, J; Yang, Z	1
Cernik, C; Haller, N; Mostow, EN	1

Other Studies

2 other study(ies) available for deferasirox and Congenital Erythropoietic Porphyria

Article	Year
Inducing iron deficiency improves erythropoiesis and photosensitivity in congenital erythropoietic porphyria. Blood, 2015, Jul-09, Volume: 126, Issue:2 Topics: Adult; Benzoates; Bone Marrow Cells; Cells, Cultured; Deferasirox; Erythropoiesis; Fatal Outcome; Female; Humans; Infant; Iron Chelating Agents; Iron Deficiencies; Light; Off-Label Use; Porphyria, Erythropoietic; Radiation Tolerance; Siblings; Triazoles	2015
Adult-onset erythropoietic porphyria in the setting of MDS. Archives of dermatology, 2009, Volume: 145, Issue:8 Topics: Aged, 80 and over; Benzoates; Deferasirox; Humans; Iron Chelating Agents; Male; Myelodysplastic Syndromes; Porphyria, Erythropoietic; Triazoles	2009

Article

Year

Inducing iron deficiency improves erythropoiesis and photosensitivity in congenital erythropoietic porphyria.

Blood, 2015, Jul-09, Volume: 126, Issue:2

Topics: Adult; Benzoates; Bone Marrow Cells; Cells, Cultured; Deferasirox; Erythropoiesis; Fatal Outcome; Female; Humans; Infant; Iron Chelating Agents; Iron Deficiencies; Light; Off-Label Use; Porphyria, Erythropoietic; Radiation Tolerance; Siblings; Triazoles

2015

Adult-onset erythropoietic porphyria in the setting of MDS.

Archives of dermatology, 2009, Volume: 145, Issue:8

Topics: Aged, 80 and over; Benzoates; Deferasirox; Humans; Iron Chelating Agents; Male; Myelodysplastic Syndromes; Porphyria, Erythropoietic; Triazoles

2009